Medicare Enrolled
Dr. Leonardo Palau, MD
Infectious Disease · The Woodlands, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Palau from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Palau?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Palau
Dr. Leonardo Palau is an infectious disease specialist in The Woodlands, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Palau performed 524,392 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Palau received a total of $38,037 from 54 pharmaceutical and/or device companies across 1593 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Palau is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 1% volume in TX
$38,037 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗524,392
Medicare services
Top 1% in TX for infectious disease
Not available
Unique patients (not deduplicated)
$1
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Daptomycin antibiotic injection | 486,103 | $0 | $0 |
| Dalbavancin injection, 5 mg An injection of the antibiotic dalbavancin, administered in a 5 mg dose. |
19,200 | $12 | $36 |
| Injection, meropenem, 100 mg | 8,698 | $0 | $3 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
3,891 | $0 | $3 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
2,552 | $48 | $132 |
| Ertapenem sodium injection, 500 mg An injection of ertapenem sodium, an antibiotic medication, administered at a dose of 500 mg. |
856 | $11 | $150 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
737 | $94 | $280 |
| Injection, cefepime hydrochloride, 500 mg | 589 | $1 | $5 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
406 | $22 | $65 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
338 | $15 | $39 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
218 | $130 | $387 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
162 | $15 | $42 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
152 | $12 | $44 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
94 | $50 | $188 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
88 | $72 | $270 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
88 | $163 | $315 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
66 | $57 | $125 |
| New patient office visit, complex (60-74 min) | 51 | $165 | $535 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
28 | $31 | $56 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
26 | $74 | $160 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
25 | $18 | $58 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
13 | $115 | $525 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
11 | $31 | $53 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.7% high complexity
99.1% medium
0.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$38,037
Total received (2018-2024)
Avg $5,434/year across 7 years
Top 9% in TX for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
1,593
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,835
2023
$5,121
2022
$5,258
2021
$7,160
2020
$3,299
2019
$4,075
2018
$8,289
Payments by company (2024)
Gilead Sciences, Inc.
$1,270
ViiV Healthcare Company
$1,023
ABBVIE INC.
$627
Cumberland Pharmaceuticals, Inc.
$338
Astellas Pharma US Inc
$244
La Jolla Pharmaceutical Company
$215
Melinta Therapeutics, LLC
$213
Merck Sharp & Dohme LLC
$210
Insmed, Inc.
$201
EMD Serono, Inc.
$119
Smith+Nephew, Inc.
$82
Shionogi Inc
$63
AIMMUNE THERAPEUTICS, INC.
$56
PFIZER INC.
$47
Takeda Pharmaceuticals U.S.A., Inc.
$33
Ferring Pharmaceuticals Inc.
$29
Seqirus USA Inc
$28
TerSera Therapeutics LLC
$22
ETS Wound Care LLC
$15
Top 3 companies account for 60.4% of 2024 payments
All-time payments by company (2018-2024) ›
Gilead Sciences, Inc.
$6,353
Organogenesis Inc.
$4,351
ViiV Healthcare Company
$4,274
CIPLA USA INC.
$2,364
Insmed, Inc.
$2,194
ABBVIE INC.
$2,068
Paratek Pharmaceuticals, Inc.
$1,696
Merck Sharp & Dohme Corporation
$1,447
Melinta Therapeutics, Inc.
$1,362
Cumberland Pharmaceuticals, Inc.
$1,359
Smith+Nephew, Inc.
$1,298
Astellas Pharma US Inc
$1,059
Melinta Therapeutics, LLC
$948
AbbVie Inc.
$820
Shionogi Inc
$711
Merck Sharp & Dohme LLC
$644
La Jolla Pharmaceutical Company
$500
Allergan Inc.
$494
Ferring Pharmaceuticals Inc.
$484
Janssen Biotech, Inc.
$385
TETRAPHASE PHARMACEUTICALS, INC.
$383
Osiris Therapeutics Inc.
$358
GRT US Holding, Inc.
$317
EMD Serono, Inc.
$274
Theravance Biopharma, Inc.
$238
Allergan, Inc.
$194
PFIZER INC.
$185
Theratechnologies Inc.
$158
Endo Pharmaceuticals Inc.
$135
MAYNE PHARMA INC.
$102
Takeda Pharmaceuticals U.S.A., Inc.
$82
ORGANOGENESIS INC.
$69
Octapharma USA, Inc.
$68
Abbott Laboratories
$67
Vyera Pharmaceuticals, LLC
$66
AIMMUNE THERAPEUTICS, INC.
$56
KCI USA, Inc
$50
Dynavax Technologies Corporation
$49
Napo Pharmaceuticals Inc
$41
Electromed, Inc.
$35
CSL Behring
$30
PORTOLA PHARMACEUTICALS, INC.
$29
HARTMANN USA, INC.
$29
Seqirus USA Inc
$28
Janssen Products, LP
$27
Tactile Systems Technology Inc
$23
TerSera Therapeutics LLC
$22
Smith & Nephew, Inc.
$19
ConvaTec Inc.
$17
Mylan Institutional Inc.
$16
ETS Wound Care LLC
$15
Nabriva Therapeutics, plc
$14
Mayne Pharma Inc.
$14
KCI USA, Inc.
$14
Top 3 companies account for 39.4% of all-time payments
Associated products mentioned in payments ›
APRETUDE · AQUACEL AG+ · AVYCAZ · Apligraf · Arikayce · BEVYXXA · Baxdela · Biktarvy · CABENUVA · COLLAGENASE SANTYL · COMIRNATY · CRESEMBA · CUTAQUIG · CUVITRU · Cimduo · Coblation · Cresemba · DALVANCE · DELSTRIGO · DIFICID · DORYX · DOVATO · Daraprim Tablet 25mg · Descovy · EGRIFTA · Epclusa · FLEXITOUCH · Fetroja · Fluad · GRAFIX · GRAFIX PL · GRAFIX/GRAFIXPL/STRAVIX · Grafix CORE · Grafix PL PRIME · GrafixPL · HYQVIA · Heplisav-B · ISENTRESS · JULUCA · KERRACEL AG · KERRAMAX CARE · Kimyrsa · LEXISCAN · MAVYRET · MIRRAGEN ADVANCED WOUND MATRIX · MYCAMINE · Mytesi · N/A · NASCOBAL · NOXAFIL · NUZYRA · Nushield · Oasis · Orbactiv · PANZYGA · PICO 7 Single Use Negative Pressure Wound Therapy · PICO7 · PIFELTRO · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PREVYMIS · PREZCOBIX · PREZISTA · PURAPLY · Privigen · Proclaim IPG · Puraply · Qutenza · Quzyttir · REBYOTA · RECARBRIO · REGRANEX · RENASYS · Rezzayo · SEROSTIM · SILVERCEL · SMARTVEST · SYMTUZA · Santyl · Serostim · Stravix · Sunlenca · Symtuza · TEFLARO · TRIUMEQ · TROGARZO · TRUMENBA · VIBATIV · VOWST · Vabomere · Veklury · Veozah · Vibativ · XERAVA · Xenleta · Xerava · ZEMDRI (PLAZOMICIN) · ZERBAXA · ZINPLAVA · Zetuvit Plus
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Infectious diseases in nearby ZIP areas
34
County median income
$97,266
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST THE WOODLANDS HOSPITAL
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Palau is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Palau experienced with daptomycin antibiotic injection?
Based on Medicare claims data, Dr. Palau performed 486,103 daptomycin antibiotic injection services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Palau receive payments from pharmaceutical companies?
Yes. Dr. Palau received a total of $38,037 from 54 companies across 1,593 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Palau's costs compare to other infectious diseases in The Woodlands?
Dr. Palau's average Medicare payment per service is $1. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Palau) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Infectious Diseases in The Woodlands
Browse infectious diseases in The Woodlands ranked by procedure volume and transparency data.
Highest volume
Top Infectious Diseases in TX
Infectious diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Infectious Diseases in TX
Which TX infectious diseases receive the most from drug and device companies.
By company
Gilead Sciences, Inc. Payments to Doctors
See all physicians who received payments from Gilead Sciences, Inc.
By company
Organogenesis Inc. Payments to Doctors
See all physicians who received payments from Organogenesis Inc.
By company
ViiV Healthcare Company Payments to Doctors
See all physicians who received payments from ViiV Healthcare Company.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology